BioCentury | Jan 21, 2021
Deals

Jan. 20 Quick Takes: Beam adds $260M; plus Lilly-Merus, Thermo Fisher-Mesa, Verve, Aclaris, ViGeneron-Daiichi Sankyo

...eligible for $540 million in milestones per product, plus royalties.Thermo Fisher buying diagnostics company MesaThermo Fisher...
...up front; the deal includes a further $100 million in milestones. The deal gives Thermo Fisher...
BioCentury | Jan 16, 2021
Product Development

Jan. 15 Quick Takes: Darzalex gains first FDA approval for form of amyloidosis; plus Thermo Fisher, Lilly, DBV, Dr. Reddy’s, Alexion, Taiho, Astellas-Actinium

...Oncology Review pilot program and Project Orbis.Thermo Fisher grows EU manufacturing presence with €725M dealThermo Fisher...
...in Belgium, for about €725 million ($884 million) in cash. The deal, which gives Thermo Fisher locations...
...terms were not disclosed. BC Staff Viaskin Peanut (DBV-712) Ultomiris, ravulizumab-cwvz (ALXN1210) Darzalex Faspro, DARA-PH20, subcutaneous daratumumab DBV Technologies S.A. Thermo Fisher...
BioCentury | Dec 22, 2020
Finance

Deerfield launches protein degradation start-up Neomorph with $109M series A

...year with scientific founders Phil Chamberlin, who serves as the company’s president and CSO; Eric Fisher...
BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...strategy and analytics. Balkin was head of data strategy and data science at Truist Securities.Thermo Fisher...
BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...“It’s the ultimate conditional gene knockout.” Stew Fisher...
...concept to get different degradation endpoints,”  Stew Fisher...
...with cereblon, and optimize them quickly,” said Fisher...
BioCentury | Sep 9, 2020
Product Development

COVID-19 roundup: SpyBiotech-Serum Institute of India send HBV-based COVID-19 vaccine to clinic; plus Vaxart, Inovio-Thermo Fisher and RedHill

...highest titers of neutralizing antibodies.Inovio, Thermo Fisher vaccine production dealInovio Pharmaceuticals Inc. (NASDAQ:INO) announced Thermo Fisher...
...which includes Richter-Helm BioLogics GmbH and Ology Bioservices Inc., for 100 million doses in 2021. Thermo Fisher...
...setting this year.TARGETSSPHK2 – Sphingosine kinase 2 BC Staff SpyBiotech Ltd. Serum Institute of India Vaxart Inc. Inovio Pharmaceuticals Inc. Thermo Fisher...
BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...Among the largest was the $2.1 billion acquisition of viral vector manufacturer Brammer Bio by Thermo Fisher...
...the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm Therapeutics Inc. Thermo Fisher...
BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...stepped down, a week after shareholders of the molecular diagnostics company rejected an $11.5 billion takeout bid from Thermo Fisher...
BioCentury | Aug 15, 2020
Product Development

Celltrion launches antigen and serology COVID-19 tests in the U.S., Verily adds capacity with CLIA lab and more

...Hanks, the lab uses the TaqPath test kit from Thermo Fisher...
BioCentury | Aug 14, 2020
Finance

Aug. 13 Quick Takes: Qiagen shareholders opt for independence; plus IPO terms from Inhibrx, Harmony and more from Biohaven-Royalty, Scioto, Bodyport, immunoSCAPE

...remain independentQiagen N.V. (NYSE:QGEN; Xetra:QIA) said it terminated its agreement to be acquired by Thermo Fisher...
...shares were tendered by Qiagen shareholders, well below the minimum threshold of 66.7% . Thermo Fisher...
...out the molecular diagnostics company for €39 ($43.33) per share, or about $11.5 billion (see “Thermo Fisher...
Items per page:
1 - 10 of 602
BioCentury | Jan 21, 2021
Deals

Jan. 20 Quick Takes: Beam adds $260M; plus Lilly-Merus, Thermo Fisher-Mesa, Verve, Aclaris, ViGeneron-Daiichi Sankyo

...eligible for $540 million in milestones per product, plus royalties.Thermo Fisher buying diagnostics company MesaThermo Fisher...
...up front; the deal includes a further $100 million in milestones. The deal gives Thermo Fisher...
BioCentury | Jan 16, 2021
Product Development

Jan. 15 Quick Takes: Darzalex gains first FDA approval for form of amyloidosis; plus Thermo Fisher, Lilly, DBV, Dr. Reddy’s, Alexion, Taiho, Astellas-Actinium

...Oncology Review pilot program and Project Orbis.Thermo Fisher grows EU manufacturing presence with €725M dealThermo Fisher...
...in Belgium, for about €725 million ($884 million) in cash. The deal, which gives Thermo Fisher locations...
...terms were not disclosed. BC Staff Viaskin Peanut (DBV-712) Ultomiris, ravulizumab-cwvz (ALXN1210) Darzalex Faspro, DARA-PH20, subcutaneous daratumumab DBV Technologies S.A. Thermo Fisher...
BioCentury | Dec 22, 2020
Finance

Deerfield launches protein degradation start-up Neomorph with $109M series A

...year with scientific founders Phil Chamberlin, who serves as the company’s president and CSO; Eric Fisher...
BioCentury | Dec 21, 2020
Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

...strategy and analytics. Balkin was head of data strategy and data science at Truist Securities.Thermo Fisher...
BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...“It’s the ultimate conditional gene knockout.” Stew Fisher...
...concept to get different degradation endpoints,”  Stew Fisher...
...with cereblon, and optimize them quickly,” said Fisher...
BioCentury | Sep 9, 2020
Product Development

COVID-19 roundup: SpyBiotech-Serum Institute of India send HBV-based COVID-19 vaccine to clinic; plus Vaxart, Inovio-Thermo Fisher and RedHill

...highest titers of neutralizing antibodies.Inovio, Thermo Fisher vaccine production dealInovio Pharmaceuticals Inc. (NASDAQ:INO) announced Thermo Fisher...
...which includes Richter-Helm BioLogics GmbH and Ology Bioservices Inc., for 100 million doses in 2021. Thermo Fisher...
...setting this year.TARGETSSPHK2 – Sphingosine kinase 2 BC Staff SpyBiotech Ltd. Serum Institute of India Vaxart Inc. Inovio Pharmaceuticals Inc. Thermo Fisher...
BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...Among the largest was the $2.1 billion acquisition of viral vector manufacturer Brammer Bio by Thermo Fisher...
...the Advanced Therapy Shipper product line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm Therapeutics Inc. Thermo Fisher...
BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...stepped down, a week after shareholders of the molecular diagnostics company rejected an $11.5 billion takeout bid from Thermo Fisher...
BioCentury | Aug 15, 2020
Product Development

Celltrion launches antigen and serology COVID-19 tests in the U.S., Verily adds capacity with CLIA lab and more

...Hanks, the lab uses the TaqPath test kit from Thermo Fisher...
BioCentury | Aug 14, 2020
Finance

Aug. 13 Quick Takes: Qiagen shareholders opt for independence; plus IPO terms from Inhibrx, Harmony and more from Biohaven-Royalty, Scioto, Bodyport, immunoSCAPE

...remain independentQiagen N.V. (NYSE:QGEN; Xetra:QIA) said it terminated its agreement to be acquired by Thermo Fisher...
...shares were tendered by Qiagen shareholders, well below the minimum threshold of 66.7% . Thermo Fisher...
...out the molecular diagnostics company for €39 ($43.33) per share, or about $11.5 billion (see “Thermo Fisher...
Items per page:
1 - 10 of 602